UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063594
Receipt number R000072776
Scientific Title Research and Development on Prevention and Health Promotion through Behavior Change App (MIRAMED): Analysis of the Effectiveness of Specific Health Guidance Using MIRAMED and Factors Associated with Behavior Change
Date of disclosure of the study information 2026/11/11
Last modified on 2026/11/11 15:33:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research and Development on Prevention and Health Promotion through Behavior Change App (MIRAMED): Analysis of the Effectiveness of Specific Health Guidance Using MIRAMED and Factors Associated with Behavior Change

Acronym

-

Scientific Title

Research and Development on Prevention and Health Promotion through Behavior Change App (MIRAMED): Analysis of the Effectiveness of Specific Health Guidance Using MIRAMED and Factors Associated with Behavior Change

Scientific Title:Acronym

-

Region

Japan


Condition

Condition

metabolic syndrome

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate changes in health indicators and lifestyle behaviors during specific health guidance using the behavior change app MIRAMED, and to explore factors associated with behavior change by integrating measurement data, health examination results, app usage data, chat data, and questionnaire data, using analytical methods including machine learning and natural language processing.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in health indicators, lifestyle behaviors, and behavior change-related measures during the specific health guidance period.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

-

Key exclusion criteria

-

Target sample size

2540


Research contact person

Name of lead principal investigator

1st name Akiko
Middle name Kishi
Last name Svensson

Organization

Graduate School of Engineering The University of Tokyo

Division name

Precision Health, Department of Bioengineering

Zip code

113-8656

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

+81-3-5481-6696

Email

akishi@g.ecc.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Kazumi
Middle name
Last name Miyamoto

Organization

MED MIRAI, Ink

Division name

Well-Being Division

Zip code

113-8656

Address

Entrepreneur Lab Utokyo South Clinical Research Bldg,.7-3-1 Hongo,Bunkyo-ku, Tokyo

TEL

090-9142-5745

Homepage URL


Email

amed@medmirai.co.jp


Sponsor or person

Institute

MED MIRAI, Ink

Institute

Department

Personal name



Funding Source

Organization

MED MIRAI, Ink

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

-

Address

-

Tel

-

Email

-


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

2540

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 11 Month 11 Day

Date of IRB

2026 Year 11 Month 11 Day

Anticipated trial start date

2026 Year 11 Month 11 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

-


Management information

Registered date

2026 Year 11 Month 11 Day

Last modified on

2026 Year 11 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072776